LeadScope

Details

DC Role: 
Project Partner

ABOUT THIS PROJECT

The ICH M7 guidance provides a specification for the use of in silico models for evaluating the genotoxicity of impurities in pharmaceuticals. The guidelines support the combined use of consensus models based on statistical-based (Q)SAR and expert rule-based computational toxicology combined with an expert opinion to support a regulatory submission. Leadscope and DC have established a partnership providing a market leading consulting service to execute the modelling and reporting requirements of such a regulatory submission. It is based on the regulatory-accepted Leadscope software developed in close collaboration with the US FDA.

 

Latest Tweets

Douglas Connect (Yesterday)
Deadline of the early-bird rate and the bursary applications for the #eChemInfo workshop is less then one week away. https://t.co/NxBAmGIFtz
Douglas Connect (2 weeks ago)
RT @barryhardy: #OpenTox Asia 2017 detailed program available #toxicology #safety #risk #3Rs #insilico #invitro #Korea @DouglasConn https:/…
Douglas Connect (3 weeks ago)
Your input is needed to the #OpenRiskNet eInfrastructure design supporting #datasharing #modelling #RiskAssessment https://t.co/ANfwQRpqVj
Douglas Connect (3 weeks ago)
"2nd Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano" https://t.co/iYP1zNEWTX on @LinkedIn
Douglas Connect (6 weeks ago)
RT @eNanoMapper: Protégé 5.2.0 released https://t.co/TGg7V4e03v (our tutorial on how to use it for our ontology: https://t.co/Dv00XOzyyB)

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com